285 related articles for article (PubMed ID: 33787270)
1. The Uniqueness of Albumin as a Carrier in Nanodrug Delivery.
Spada A; Emami J; Tuszynski JA; Lavasanifar A
Mol Pharm; 2021 May; 18(5):1862-1894. PubMed ID: 33787270
[TBL] [Abstract][Full Text] [Related]
2. Efficient delivery of therapeutic agents by using targeted albumin nanoparticles.
Kouchakzadeh H; Safavi MS; Shojaosadati SA
Adv Protein Chem Struct Biol; 2015; 98():121-43. PubMed ID: 25819278
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery.
Fu Q; Sun J; Zhang W; Sui X; Yan Z; He Z
Recent Pat Anticancer Drug Discov; 2009 Nov; 4(3):262-72. PubMed ID: 19538176
[TBL] [Abstract][Full Text] [Related]
4. Using nanotechnology to improve the characteristics of antineoplastic drugs: improved characteristics of nab-paclitaxel compared with solvent-based paclitaxel.
Foote M
Biotechnol Annu Rev; 2007; 13():345-57. PubMed ID: 17875482
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel.
Stinchcombe TE
Nanomedicine (Lond); 2007 Aug; 2(4):415-23. PubMed ID: 17716129
[TBL] [Abstract][Full Text] [Related]
6. Protein nanoparticles in drug delivery: animal protein, plant proteins and protein cages, albumin nanoparticles.
Kianfar E
J Nanobiotechnology; 2021 May; 19(1):159. PubMed ID: 34051806
[TBL] [Abstract][Full Text] [Related]
7. Albumin-Based Nanodevices as Drug Carriers.
Loureiro A; Azoia NG; Gomes AC; Cavaco-Paulo A
Curr Pharm Des; 2016; 22(10):1371-90. PubMed ID: 26806342
[TBL] [Abstract][Full Text] [Related]
8. nab-Paclitaxel mechanisms of action and delivery.
Yardley DA
J Control Release; 2013 Sep; 170(3):365-72. PubMed ID: 23770008
[TBL] [Abstract][Full Text] [Related]
9. Albumin-bound paclitaxel: a next-generation taxane.
Gradishar WJ
Expert Opin Pharmacother; 2006 Jun; 7(8):1041-53. PubMed ID: 16722814
[TBL] [Abstract][Full Text] [Related]
10. Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer.
Kinoshita R; Ishima Y; Chuang VTG; Nakamura H; Fang J; Watanabe H; Shimizu T; Okuhira K; Ishida T; Maeda H; Otagiri M; Maruyama T
Biomaterials; 2017 Sep; 140():162-169. PubMed ID: 28651144
[TBL] [Abstract][Full Text] [Related]
11. Protein nanoparticles as drug carriers in clinical medicine.
Hawkins MJ; Soon-Shiong P; Desai N
Adv Drug Deliv Rev; 2008 May; 60(8):876-85. PubMed ID: 18423779
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel.
Petrelli F; Borgonovo K; Barni S
Expert Opin Pharmacother; 2010 Jun; 11(8):1413-32. PubMed ID: 20446855
[TBL] [Abstract][Full Text] [Related]
13. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.
Battogtokh G; Kang JH; Ko YT
Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785
[TBL] [Abstract][Full Text] [Related]
14. Liposome encapsulated albumin-paclitaxel nanoparticle for enhanced antitumor efficacy.
Ruttala HB; Ko YT
Pharm Res; 2015 Mar; 32(3):1002-16. PubMed ID: 25213777
[TBL] [Abstract][Full Text] [Related]
15. Current trends in the use of human serum albumin for drug delivery in cancer.
Paul M; Itoo AM; Ghosh B; Biswas S
Expert Opin Drug Deliv; 2022 Nov; 19(11):1449-1470. PubMed ID: 36253957
[TBL] [Abstract][Full Text] [Related]
16. Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer.
Guarneri V; Dieci MV; Conte P
Expert Opin Pharmacother; 2012 Feb; 13(3):395-406. PubMed ID: 22263900
[TBL] [Abstract][Full Text] [Related]
17. Impact of albumin on drug delivery--new applications on the horizon.
Elsadek B; Kratz F
J Control Release; 2012 Jan; 157(1):4-28. PubMed ID: 21959118
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
[TBL] [Abstract][Full Text] [Related]
19. Serum albumin: clinical significance of drug binding and development as drug delivery vehicle.
Tayyab S; Feroz SR
Adv Protein Chem Struct Biol; 2021; 123():193-218. PubMed ID: 33485484
[TBL] [Abstract][Full Text] [Related]
20. Drug-binding albumins forming stabilized nanoparticles for co-delivery of paclitaxel and resveratrol: In vitro/in vivo evaluation and binding properties investigation.
Zhao Y; Cai C; Liu M; Zhao Y; Wu Y; Fan Z; Ding Z; Zhang H; Wang Z; Han J
Int J Biol Macromol; 2020 Jun; 153():873-882. PubMed ID: 32169451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
